相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Angela M. Mitchell et al.
CURRENT GENE THERAPY (2012)
Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents
Roberto Calcedo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes
F. Sonntag et al.
JOURNAL OF VIROLOGY (2011)
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
Ivonne Rubio et al.
VIROLOGY (2011)
Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
Melissa Bartel et al.
FRONTIERS IN MICROBIOLOGY (2011)
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin et al.
HUMAN GENE THERAPY (2010)
A viral assembly factor promotes AAV2 capsid formation in the nucleolus
Florian Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations
Jorge Boucas et al.
JOURNAL OF GENE MEDICINE (2009)
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses
Roberto Calcedo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
Subhashini Jagu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human Papillomavirus
Katherine M. Johnson et al.
JOURNAL OF VIROLOGY (2009)
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
Christina Schellenbacher et al.
JOURNAL OF VIROLOGY (2009)
Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure
Valérie Guyard-Dangremont et al.
PROTEIN SCIENCE (2009)
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20-38) peptide displayed on bacterial thioredoxin
Ivonne Rubio et al.
VACCINE (2009)
Heparan Sulfate-Independent Cell Binding and Infection with Furin-Precleaved Papillomavirus Capsids
Patricia M. Day et al.
JOURNAL OF VIROLOGY (2008)
Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies
Patricia M. Day et al.
JOURNAL OF VIROLOGY (2008)
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2
Hannah H. Alphs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A protective and broadly cross-neutralizing epitope of human papillomavirus L2
Ratish Gambhira et al.
JOURNAL OF VIROLOGY (2007)
How do adjuvants work? Important considerations for new generation adjuvants
Amy S. Mckee et al.
IMMUNITY (2007)
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2
Ratish Gambhira et al.
JOURNAL OF VIROLOGY (2007)
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan
Jeffrey N. Roberts et al.
NATURE MEDICINE (2007)
The perfect mix: recent progress in adjuvant research
Bruno Guy
NATURE REVIEWS MICROBIOLOGY (2007)
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11
Katharina Slupetzky et al.
VACCINE (2007)
Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV 16 minor capsid protein L2 surface region
Kazunari Kondo et al.
VIROLOGY (2007)
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells
Timothy D. Culp et al.
JOURNAL OF VIROLOGY (2006)
Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1
D Kuck et al.
JOURNAL OF VIROLOGY (2006)
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2
DV Pastrana et al.
VIROLOGY (2005)
Custom adeno-associated virus capsids: The next generation of recombinant vectors with novel tropism
N Muzyczka et al.
HUMAN GENE THERAPY (2005)
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18
DV Pastrana et al.
VIROLOGY (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Q Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes
RBS Roden et al.
VIROLOGY (2000)
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
P Wu et al.
JOURNAL OF VIROLOGY (2000)
分享论文
